Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%. The data ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...

Researchers from Kyushu University have developed an innovative computational method, called ddHodge, that can reconstruct ...

Share on Pinterest Are researchers getting closer to functionally curing type 1 diabetes? Image credit: Costfoto/NurPhoto via Getty Images. A woman has undergone a stem-cell therapy made from her own ...